Fusion Pharmaceuticals (FUSN) has filed an updated preliminary prospectus for its IPO of 8.35M common shares at $14-16 per share.
Underwriters’ over-allotment is an additional ~1.25M shares.
https://seekingalpha.com/news/3584812-fusion-pharmaceuticals-sets-ipo-terms
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.